Binh An Phan, MD


Dr. Binh An P. Phan is a Clinical Professor of Medicine at UCSF and a non-invasive, general cardiologist in the Division of Cardiology at Zuckerberg San Francisco. After receiving his medical degree from the University of Michigan, he completed internal medicine residency, cardiology fellowship, and post-doctoral research fellowship training at the University of Washington Hospitals in Seattle, Washington.

Dr. Phan joined the UCSF faculty in 2014 and previously was on faculty at the Loyola University School of Medicine. He is currently the Division’s Director of Inpatient Cardiology Services and the Director for Medical Education. He has special interests in undergraduate and graduate medical education and currently serves as a UCSF School of Medicine Bridges coach for medical students. He has received numerous teaching awards at UCSF, including the UCSF Academic Senate Distinction in Teaching Award and the Henry J. Kaiser Award for Excellence in Teaching.
Diversity, Equity, and Inclusion Champion Training, - , University of California, San Francisco
Doctor of Medicine, - School of Medicine, University of Michigan
Fellowship, - Cardiology, University of Washington
Postdoctoral Research Fellowship, - Cardiovascular Medicine, University of Washington
Residency, - Internal Medicine, University of Washington
Honors and Awards
  • Haile T. Debas Academy of Medical Educators Excellence in Teaching Award, UCSF, 2020
  • ZSFG Department of Medicine Mentoring Award, UCSF Department of Medicine, 2020
  • Academic Senate Distinction in Teaching Award, UCSF, 2018
  • Distinction in Medical Education, UCSF Department of Medicine, 2018
  • Bridges Curriculum Commitment to Teaching Award, UCSF School of Medicine, 2018
  • Floyd C. Rector Jr., Housestaff Teaching Award, UCSF Department of Medicine, 2017
  • Joel Karliner Faculty Teaching Award, UCSF Division of Cardiology, 2017
  • Osler Distinguished Teacher Award, UCSF School of Medicine, 2017
  • Henry F. Chambers Medicine Subspecialist Consultant of the Year Award, UCSF Department of Medicine, 2016
  • Henry J. Kaiser Award for Excellence in Teaching, UCSF School of Medicine, 2016
  1. Association between statin use, atherosclerosis, and mortality in HIV-infected adults.
  2. Lp(a) (Lipoprotein(a)) Levels Predict Progression of Carotid Atherosclerosis in Subjects With Atherosclerotic Cardiovascular Disease on Intensive Lipid Therapy: An Analysis of the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/
  3. Utility of 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines in HIV-Infected Adults With Carotid Atherosclerosis.
  4. Galloping Heart.
  5. Mortality reduction in patients treated with long-term intensive lipid therapy: 25-year follow-up of the Familial Atherosclerosis Treatment Study-Observational Study.
  6. Epicardial adipose tissue-Truly at the heart of the coronaries?
  7. Proprotein convertase subtilisin/kexin type 9 inhibition: a new therapeutic mechanism for reducing cardiovascular disease risk.
  8. Statin Alternatives: A Review of Over-the-Counter Lipid-Lowering Supplements
  9. Cardiovascular Effects of Exposure to Cigarette Smoke and Electronic Cigarettes: Clinical Perspectives From the Prevention of Cardiovascular Disease Section Leadership Council and Early Career Councils of the American College of Cardiology.
  10. Thrombus-in-transit entrapped in a patent foramen ovale and related to underlying antiphospholipid syndrome.
  11. Prolonged combination lipid therapy is associated with reduced carotid intima-media thickness: a case-control study of the 20-year Familial Atherosclerosis Treatment - Observational Study (FATS-OS).
  12. Lipid-lowering therapy in patients 75 years and older: clinical priority or superfluous therapy?
  13. Dyslipidemia in women: etiology and management.
  14. Lipoprotein(a): epidemiology, atherogenic activity, and impact on cardiovascular risk
  15. Is the future of statins aligned with new novel lipid modulation therapies?
  16. Effects of niacin on glucose levels, coronary stenosis progression, and clinical events in subjects with normal baseline glucose levels (<100 mg/dl): a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), HDL-Atherosclerosis Treatment
  17. Ezetimibe therapy: mechanism of action and clinical update.
  18. MR imaging of carotid plaque composition during lipid-lowering therapy a prospective assessment of effect and time course.
  19. Effects of adding extended-release niacin and colesevelam to statin therapy on lipid levels in subjects with atherosclerotic disease.
  20. Testing the hypothesis of atherosclerotic plaque lipid depletion during lipid therapy by magnetic resonance imaging: study design of Carotid Plaque Composition Study.
  21. Association of high-density lipoprotein levels and carotid atherosclerotic plaque characteristics by magnetic resonance imaging.
  22. Confirmation of Chagas' cardiomyopathy following heart transplantation.
  23. Effect of contrast enhancement on the measurement of carotid arterial lumen and wall volume using MRI.
  24. Reproducibility of carotid atherosclerotic lesion type characterization using high resolution multicontrast weighted cardiovascular magnetic resonance.